The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system

Cases of progressive multifocal leukoencephalopathy can occur in patients treated with the B cell depleting anti-CD20 antibody, rituximab, highlighting the importance of B cell surveillance of the central nervous system (CNS). The lymphoid chemokine, CXCL13, is critical for B cell recruitment and fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rainey-Barger, Emily K., Rumble, Julie M., Lalor, Stephen J., Esen, Nilufer, Segal, Benjamin M., Irani, David N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135968/
https://www.ncbi.nlm.nih.gov/pubmed/20933590
http://dx.doi.org/10.1016/j.bbi.2010.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135968/
https://www.ncbi.nlm.nih.gov/pubmed/20933590
http://dx.doi.org/10.1016/j.bbi.2010.10.002

Ejemplares similares